Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ayad, 1998, The extracellular matrix facts book
Bächinger, 1991, Sequence specific thermal stability of the collagen triple helix, Int J Biol Macromol, 13, 152, 10.1016/0141-8130(91)90040-2
Bächinger, 1993, Thermal stability and folding of the collagen triple helix and the effects of mutations in osteogenesis imperfecta on the helix of type I collagen, Am J Med Genet, 45, 152, 10.1002/ajmg.1320450204
Barnes AM, Chang W, Morello R, Cabral WA, Weis MA, Eyre DR, Makareeva E, Kouznetsova N, Leikin S, Uveges TE, Mulvihill JJ, Wilson PL, Sundaram UT, Lee B, Marini JC. 2006. Recessive lethal form of osteogenesis imperfecta caused by null mutations in CRTAP. 28th Annual Meeting of American Society of Bone and Mineral Research, Philadelphia, PA. Abstract 922.
Baronas-Lowell, 2004, Induction of endothelial cell activation by a triple helical α2β1 integrin ligand, derived from type I collagen α1(I)496-507, J Biol Chem, 279, 952, 10.1074/jbc.M305989200
Byers, 2002, Connective tissue and its heritable disorders: molecular, genetic and medical aspects, 385, 10.1002/0471221929.ch8
Byers, 1991, Osteogenesis imperfecta: translation of mutation to phenotype, J Med Genet, 28, 433, 10.1136/jmg.28.7.433
Cabral, 2005, Mutations near amino end of α1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing, J Biol Chem, 280, 19259, 10.1074/jbc.M414698200
Canty, 2005, Procollagen trafficking, processing and fibrillogenesis, J Cell Sci, 118, 1341, 10.1242/jcs.01731
Chakravarti, 1998, Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican, J Cell Biol, 141, 1277, 10.1083/jcb.141.5.1277
Chapman, 1974, The staining pattern of collagen fibrils. I. An analysis of electron micrographs, Connect Tissue Res, 2, 137, 10.3109/03008207409152099
Chu, 1983, Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta, Nature, 304, 78, 10.1038/304078a0
Chu, 2002, Connective tissue and its heritable disorders: molecular, genetic and medical aspects, 223, 10.1002/0471221929.ch2(ii)
Colige, 1997, cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components, Proc Natl Acad Sci USA, 94, 2374, 10.1073/pnas.94.6.2374
Dahl, 1998, Type I collagen-phosphophoryn interactions: specificity of the monomer-monomer binding, J Struct Biol, 123, 162, 10.1006/jsbi.1998.4025
Dalgleish, 1997, The human type I collagen mutation database, Nucleic Acids Res, 25, 181, 10.1093/nar/25.1.181
Dalgleish, 1998, The Human Collagen Mutation Database 1998, Nucleic Acids Res, 26, 253, 10.1093/nar/26.1.253
den Dunnen, 2001, Nomenclature for the description of human sequence variations, Hum Genet, 109, 121, 10.1007/s004390100505
den Dunnen, 2003, Standardizing mutation nomenclature: why bother?, Hum Mutat, 22, 181, 10.1002/humu.10262
Di Lullo, 2002, Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen, J Biol Chem, 277, 4223, 10.1074/jbc.M110709200
Dzamba, 1993, Fibronectin binding site in type I collagen regulates fibronectin fibril formation, J Cell Biol, 121, 1165, 10.1083/jcb.121.5.1165
Engel, 1991, The zipper-like folding of collagen triple helices and the effects of mutations that disrupt the zipper, Annu Rev Biophys Biophys Chem, 20, 137, 10.1146/annurev.bb.20.060191.001033
Font, 1998, Structural requirements for fibromodulin binding to collagen and the control of type I collagen fibrillogenesis-critical roles for disulphide bonding and the C-terminal region, Eur J Biochem, 254, 580, 10.1046/j.1432-1327.1998.2540580.x
Forlino, 2000, Osteogenesis imperfecta: prospects for molecular therapeutics, Mol Genet Metab, 71, 225, 10.1006/mgme.2000.3039
Genovese, 1987, Analysis of cytoplasmic and nuclear messenger RNA in fibroblasts from patients with type I osteogenesis imperfecta, Methods Enzymol, 145, 223, 10.1016/0076-6879(87)45012-X
Hadley, 1998, Glycation changes the charge distribution of type I collagen fibrils, Glycoconj J, 15, 835, 10.1023/A:1006928403140
Hanson, 1996, Molecular site specificity of pyridinoline and pyrrole cross-links in type I collagen of human bone, J Biol Chem, 271, 26508, 10.1074/jbc.271.43.26508
Keene, 2000, Decorin binds near the C terminus of type I collagen, J Biol Chem, 275, 21801, 10.1074/jbc.C000278200
Kleinman, 1976, Localization of the cell attachment region in types I and II collagens, Biochem Biophys Res Commun, 72, 426, 10.1016/S0006-291X(76)80060-5
Kleinman, 1978, Localization of the binding site for cell attachment in the α1(I) chain of collagen, J Biol Chem, 253, 5642, 10.1016/S0021-9258(17)30315-0
Körkk, 1998, Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations, Am J Hum Genet, 62, 98, 10.1086/301689
Kuivaniemi, 1991, Mutations in collagen genes: causes of rare and some common diseases in humans, FASEB J, 5, 2052, 10.1096/fasebj.5.7.2010058
Kuivaniemi, 1997, Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vessels, Hum Mutat, 9, 300, 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9
Kyriakides, 1998, Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis, J Cell Biol, 140, 419, 10.1083/jcb.140.2.419
Lauer-Fields, 2000, Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases, J Biol Chem, 275, 13282, 10.1074/jbc.275.18.13282
Malfait, 2006, Total absence of the α2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems, J Med Genet, 43, e36, 10.1136/jmg.2005.038224
Marini, 1989, Osteogenesis imperfecta type IV. Detection of a point mutation in one α1(I) collagen allele (COL1A1) by RNA/RNA hybrid analysis, J Biol Chem, 264, 11893, 10.1016/S0021-9258(18)80150-8
Marini, 1993, Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiology, J Biol Chem, 268, 2667, 10.1016/S0021-9258(18)53826-6
Marini, 2004, Nelson's textbook of pediatrics, 2336
Persikov, 2004, Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disorders, Hum Mutat, 24, 330, 10.1002/humu.20091
Persikov, 2005, Prediction of collagen stability from amino acid sequence, J Biol Chem, 280, 19343, 10.1074/jbc.M501657200
Pietz, 1984, Extracellular matrix biochemistry
Prockop, 1989, Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue, Am J Med Genet, 34, 60, 10.1002/ajmg.1320340112
Prockop, 1993, Mutations in type I procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies, J Bone Miner Res, 8, S489, 10.1002/jbmr.5650081311
Prockop, 1998, Inhibition of the self-assembly of collagen I into fibrils with synthetic peptides, Demonstration that assembly is driven by specific binding sites on the monomers. J Biol Chem, 273, 15598
Redford-Badwal, 1996, Nuclear retention of COL1A1 messenger RNA identifies null alleles causing mild osteogenesis imperfecta, J Clin Invest, 97, 1035, 10.1172/JCI118495
Reiser, 1992, Nonenzymatic glycation of type I collagen. The effects of aging on preferential glycation sites, J Biol Chem, 267, 24207, 10.1016/S0021-9258(18)35751-X
Reyes, 2004, α2β1 integrin-specific collagen-mimetic surfaces supporting osteoblastic differentiation, J Biomed Mater Res A, 69, 591, 10.1002/jbm.a.30034
Rosenberg, 1998, Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen, J Biol Chem, 273, 20397, 10.1074/jbc.273.32.20397
San Antonio, 1994, Mapping the heparin-binding sites on type I collagen monomers and fibrils, J Cell Biol, 125, 1179, 10.1083/jcb.125.5.1179
Schlessinger, 1997, Direct binding and activation of receptor tyrosine kinases by collagen, Cell, 91, 869, 10.1016/S0092-8674(00)80477-8
Schorderet, 1992, Analysis of CpG suppression in methylated and nonmethylated species, Proc Natl Acad Sci USA, 89, 957, 10.1073/pnas.89.3.957
Schwarze, 2004, Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway, Am J Hum Genet, 74, 917, 10.1086/420794
Scott, 1991, Proteoglycan: collagen interactions in connective tissues. Ultrastructural, biochemical, functional and evolutionary aspects, Int J Biol Macromol, 13, 157, 10.1016/0141-8130(91)90041-R
Scott, 1997, Peptide sequences in glutaraldehyde-linked proteodermatan sulphate: collagen fragments from rat tail tendon locate the proteoglycan binding sites, Biochem Soc Trans, 25, S663, 10.1042/bst025s663
Shrivastava, 1997, An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors, Mol Cell, 1, 25, 10.1016/S1097-2765(00)80004-0
Sillence, 1979, Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity, Birth Defects Orig Artic Ser, 15, 113
Sillence, 1979, Genetic heterogeneity in osteogenesis imperfecta, J Med Genet, 16, 101, 10.1136/jmg.16.2.101
Slayton, 2000, Nonsense mutations in the COL1A1 gene preferentially reduce nuclear levels of mRNA but not hnRNA in osteogenesis imperfecta type I cell strains, Matrix Biol, 19, 1, 10.1016/S0945-053X(99)00056-6
Svensson, 1999, Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon, J Biol Chem, 274, 9636, 10.1074/jbc.274.14.9636
Sweeney, 1998, Defining the domains of type I collagen involved in heparin-binding and endothelial tube formation, Proc Natl Acad Sci USA, 95, 7275, 10.1073/pnas.95.13.7275
Sweeney, 2003, Angiogenesis in collagen I requires α2β1 ligation of a GFP*GER sequence and possibly p38 MAPK activation and focal adhesion disassembly, J Biol Chem, 278, 30516, 10.1074/jbc.M304237200
Vogel, 1997, The discoidin domain receptor tyrosine kinases are activated by collagen, Mol Cell, 1, 13, 10.1016/S1097-2765(00)80003-9
Wang, 1993, Two additional cases of osteogenesis imperfecta with substitutions for glycine in the α2(I) collagen chain. A regional model relating mutation location with phenotype, J Biol Chem, 268, 25162, 10.1016/S0021-9258(19)74583-9
Willing, 1992, Osteogenesis imperfecta type I is commonly due to a COL1A1 null allele of type I collagen, Am J Hum Genet, 51, 508
Willing, 1994, Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen, Am J Hum Genet, 55, 638
Willing, 1996, Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains, Am J Hum Genet, 59, 799